{"id":467,"date":"2026-10-14T19:50:48","date_gmt":"2026-10-15T00:50:48","guid":{"rendered":"https:\/\/diezcanseco.pe\/?p=467"},"modified":"2026-10-15T09:45:18","modified_gmt":"2026-10-15T14:45:18","slug":"boletin-regula-360-edicion-agosto-2026","status":"publish","type":"post","link":"https:\/\/diezcanseco.pe\/en\/insights\/boletin-regula-360-edicion-agosto-2026\/","title":{"rendered":"REGULA 360\u00b0 Newsletter | August 2026 Edition"},"content":{"rendered":"<h3 class=\"wp-block-heading\">REGULATIONS<\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>AMENDMENT TO THE LIST OF DOCUMENTS EQUIVALENT TO THE GOOD MANUFACTURING PRACTICES (GMP) CERTIFICATE<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 08, 2026, Directorial Resolution No. 121-2026-DIGEMID-DG-MINSA was published in the Official Gazette \u201cEl Peruano\u201d, amending the \u201cList of Documents Considered Equivalent to the Certificate of Good Manufacturing Practices\u201d.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Why is it important?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pursuant to Supreme Decree No. 012-2023-SA, until May 23, 2028 DIGEMID will accept, for the import of pharmaceutical products, Good Manufacturing Practices Certificates issued by the Competent Authority of the country of origin or documents recognized as equivalent. This applies provided that the manufacturing laboratories are included in the Single List of Manufacturing Laboratories of Pharmaceutical Products located abroad pending Good Manufacturing Practices certification.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In this context, DIGEMID, as the National Authority for Pharmaceutical Products, Medical Devices and Sanitary Products, is responsible for approving by Directorial Resolution the list of documents considered equivalent to the Good Manufacturing Practices Certificate.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What is amended?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Directorial Resolution No. 121-2026-DIGEMID-DG-MINSA reincorporates the Certificate of Pharmaceutical Product (CPP) issued by the European Medicines Agency (EMA) as a document equivalent to the Good Manufacturing Practices Certificate.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Thus, the Certificate of Pharmaceutical Product indicating compliance with Good Manufacturing Practices, and which covers only the pharmaceutical product for which it was issued, may come from the following authorities:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Authorities of High Sanitary Surveillance Countries;<\/li>\n\n\n\n<li>National Medical Products Administration (NMPA) or its local regulatory departments, for the People&#039;s Republic of China; and<\/li>\n\n\n\n<li>European Medicines Agency (EMA), for European Union countries.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">This last alternative is the amendment introduced by the new resolution, since the list approved in June 2026 only contemplated, for the CPP, the authorities of High Sanitary Surveillance Countries and the NMPA or its local regulatory departments.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Resolution also provides that administrative proceedings that were pending when Directorial Resolution No. 063-2026-DIGEMID-DG-MINSA entered into force shall be governed by this amendment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2541050-1\" target=\"_blank\" rel=\"noopener\">https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2541050-1<\/a><\/p>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><strong>AMENDMENT TO THE REGULATIONS FOR THE COLLECTION, TRANSFER AND DISSEMINATION OF INFORMATION ON HEALTH SERVICES GENERATED BY IPRESS AND UGIPRESS<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 12, 2026, Superintendency Resolution No. 000118-2026- SUSALUD\/SUP was published in the Official Gazette \u201cEl Peruano\u201d, amending the \u201cRegulations for the Collection, Transfer and Dissemination of Information on Health Services generated by Health Service Provider Institutions (IPRESS) and IPRESS Management Units (UGIPRESS)\u201d, approved by Superintendency Resolution No. 092-2014-SUSALUD\/S.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What is amended?<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong><em>IPRESS I-3: the rule applicable in the event of a change of category is amended<\/em><\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">For I-3 IPRESS, the start of the obligation remains as of July 1, 2025. However, the rule for a subsequent recategorization to a lower level is now regulated: if by that date an IPRESS changes to level I-4, it keeps the deadline assigned to category I-3; if it changes to a lower level, the deadline assigned to the lower level applies.<\/p>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><strong><em>IPRESS I-2: the start of the obligation is postponed and Support Medical Services are expressly included<\/em><\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">The Resolution specifies that category I-2 IPRESS and IPRESS registered in RENIPRESS as Support Medical Services (SMA) must begin sending such information as of January 1, 2027, with respect to the schedule for the following month.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It also amends the categorization rule:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Before: if an I-2 changed to I-1 or higher, it kept the 1-2 deadline.<\/li>\n\n\n\n<li>Now: it is generally provided that, if it changes category, it keeps the deadline assigned to category I-2.<\/li>\n<\/ul>\n\n\n\n<ol start=\"3\" class=\"wp-block-list\">\n<li><strong><em>New IPRESS: a 6-month implementation period is established<\/em><\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">It is established that a new IPRESS has six (6) months to implement the submission of its care schedule, counted from the date of issuance of its Categorization or Classification Resolution by the health authority, respecting the deadlines corresponding to each category or classification.<\/p>\n\n\n\n<ol start=\"4\" class=\"wp-block-list\">\n<li><strong><em>Incorporation of article 13-A: Compliance indicator applicable to the first level of care<\/em><\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">A Compliance Indicator is incorporated to evaluate the submission of information by public, private or mixed IPRESS and UGIPRESS. The indicator considers the proportion of months in which the submission was made within the established deadline, over a total evaluation period of six months.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The indicator must be equal to or greater than 80%. Non-compliance is subject to the provisions of SUSALUD&#039;s Regulations on Infractions and Sanctions. Likewise, the subsequent regularization of a late submission does not eliminate the infraction or interrupt the calculation of the indicator.<\/p>\n\n\n\n<ol start=\"5\" class=\"wp-block-list\">\n<li><strong><em>Deadlines for the implementation of SETI-IPRESS are extended<\/em><\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">For first-level-of-care IPRESS, the implementation deadlines for SETI-IPRESS applicable to Annex 1 are established as follows:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Category I-4 has a deadline that expired on December 31, 2024.<\/li>\n\n\n\n<li>Category I-3 has a deadline that expires on December 31, 2026.<\/li>\n\n\n\n<li>Category I-2 and IPRESS registered in RENIPRESS as Support Medical Services have a deadline that expires on December 31, 2027.<\/li>\n\n\n\n<li>Category I-1 has a deadline that expires on December 31, 2028.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2542395-1\" target=\"_blank\" rel=\"noopener\">https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2542395-1<\/a><\/p>\n\n\n\n<ol start=\"3\" class=\"wp-block-list\">\n<li><strong>SENASA ESTABLISHES PHYTOSANITARY MEASURES FOR THE PHYTOSANITARY CERTIFICATION OF PLANT PRODUCTS INTENDED FOR EXPORT<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 14, 2026, Directorial Resolution No. D000028-2026-MIDAGRI- SENASA-DSV was published in the Official Gazette \u201cEl Peruano\u201d, approving the Document entitled \u201cPhytosanitary measures for the phytosanitary certification of plant products intended for export\u201d, applicable to exporters, packing plants and treatment and packing plants.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In turn, any provision contrary to the provisions of the published Resolution was rendered void.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Why is it important?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The purpose of the document is to ensure that plant products intended for export comply with national and international regulations, as well as with the specific phytosanitary requirements established by the authorities of importing countries. Its application covers plant products in risk categories 2 and 3 of ISPM No. 32.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Consequently, the new measures set out in detail the operational conditions that must be observed throughout the export chain, from the entry of the plant product into the packing plant until its dispatch, maintaining phytosanitary safeguard and traceability conditions at all times.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The main obligations include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Verifying that the raw material comes from production sites certified by SENASA and assigning each lot a unique code that ensures its traceability.<\/li>\n\n\n\n<li>Carrying out primary and secondary pest assessments, as well as, where applicable, determination of dry matter and other phytosanitary risk mitigation measures.<\/li>\n\n\n\n<li>Complying with certain conditions during the cleaning, washing, disinfection, brushing, sorting, waxing, drying, labeling and cold chain handling stages.<\/li>\n\n\n\n<li>Keeping facilities under phytosanitary safeguard, suspending operations in affected areas when a pest is detected, until the corresponding measures are implemented and verified.<\/li>\n\n\n\n<li>Submitting, at the beginning of each export season and when applicable, a letter of commitment, declaring the linked production sites and keeping the information registered with SENASA up to date.<\/li>\n\n\n\n<li>Submitting phytosanitary certification requests mainly through VUCE and requesting inspections, as a general rule, by 3:00 p.m. on the day before the scheduled date.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Likewise, packing plants where phytosanitary inspections are carried out must be authorized by SENASA and have video surveillance cameras in the sampling, inspection and loading areas, keeping the recordings for a period of sixty (60) days.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The document also sets out the conditions applicable to phytosanitary treatments for export purposes, including cold treatments, hydrothermal treatment and fumigations, when required by the phytosanitary authority of the importing country.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Finally, it is specified that the technical annexes, including those corresponding to the traceability system, cold treatments, hydrothermal treatments, fumigations, electronic certification and specific measures by plant product, will be published and updated by SENASA on its digital platform.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Who is affected?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Mainly exporters of plant products, packing plants and treatment and packing plants involved in the export of products in phytosanitary risk categories 2 and 3.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/www.gob.pe\/institucion\/senasa\/normaslegales\/8480370-028-2026-midagri-senasa-dsv\" target=\"_blank\" rel=\"noopener\">https:\/\/www.gob.pe\/institucion\/senasa\/normaslegales\/8480370-028-2026-midagri-senasa-dsv<\/a><\/p>\n\n\n\n<ol start=\"4\" class=\"wp-block-list\">\n<li><strong>NEW DIRECTOR GENERAL OF DIRIS LIMA SUR APPOINTED<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 16, 2026, Ministerial Resolution No. 701-2026\/MINSA was published in the Official Gazette \u201cEl Peruano\u201d, through which the Ministry of Health \u2013 MINSA appoints the new Director General of the Directorate of Integrated Health Networks Lima Sur \u2013 DIRIS Lima Sur.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What does it provide?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ministerial Resolution No. 701-2026\/MINSA appoints Mr. Mario Eduardo Izquierdo Hernandez to the position of Director General (CAP-P No. 001) of the Directorate of Integrated Health Networks Lima Sur of the Ministry of Health.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2543984-1\" target=\"_blank\" rel=\"noopener\">https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2543984-1<\/a><\/p>\n\n\n\n<ol start=\"5\" class=\"wp-block-list\">\n<li><strong>NEW DIRECTOR OF SENASA&#039;S PLANT QUARANTINE SUBDIRECTORATE APPOINTED<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 17, 2026, Head Resolution No. D000124-2026-MIDAGRI-SENASA- JN was published in the Official Gazette \u201cEl Peruano\u201d, appointing the new Director of the Plant Quarantine Subdirectorate of the Plant Health Directorate of the National Agrarian Health Service \u2013 SENASA.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What does it provide?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Head Resolution No. D000124-2026-MIDAGRI-SENASA-JN appoints Ms. Mar\u00eda Ver\u00f3nica del Rosario S\u00e1nchez Valencia as Director of the Plant Quarantine Subdirectorate of the Plant Health Directorate.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/busquedas.elperuano.pe\/dispositivo\/EX\/2544316-1\" target=\"_blank\" rel=\"noopener\">https:\/\/busquedas.elperuano.pe\/dispositivo\/EX\/2544316-1<\/a><\/p>\n\n\n\n<ol start=\"6\" class=\"wp-block-list\">\n<li><strong>SENASA ESTABLISHES NEW PHYTOSANITARY REQUIREMENTS FOR THE IMPORT OF TRUE SEEDS<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 20, 2026, Directorial Resolution No. D000030-2026-MIDAGRI- SENASA-DSV was published in the Official Gazette \u201cEl Peruano\u201d, through which the National Agrarian Health Service \u2013 SENASA establishes new mandatory general phytosanitary requirements for the import of true seeds, regardless of their quantity and use.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Why is it important?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">During the 2016-2024 period, SENASA detected quarantine pests in true seed import processes. In view of this, the authority determined the need to update the general phytosanitary requirements applicable to these products, particularly regarding their identification, sampling and phytosanitary analysis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">SENASA also determined that the type of packaging used to transport the seeds is not a measure that mitigates phytosanitary risk. Therefore, the Resolution provides that all shipments of true seeds, regardless of the type of packaging, must undergo phytosanitary analysis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What do they establish?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Resolution establishes, among others, the following general requirements for the import of true seeds:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Having a phytosanitary import permit issued by SENASA before certification and shipment in the country of origin or provenance.<\/li>\n\n\n\n<li>Having an official phytosanitary export or re-export certificate issued by the phytosanitary authority of the country of origin or provenance.<\/li>\n\n\n\n<li>Seeds must be in new, first-use packaging, free of soil, plant debris or other seeds. The packaging must also indicate the name of the product and the country of origin.<\/li>\n\n\n\n<li>Shipments will be subject to phytosanitary inspection at the point of entry into the country.<\/li>\n\n\n\n<li>During the inspection, SENASA will take a sample for analysis by the Plant Health Diagnostic Center Unit. The shipment will remain detained until the results are obtained and the diagnostic costs will be borne by the importer.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">As an exception, for shipments not exceeding two (2) kilograms per species and origin, as well as seeds intended for planting for subsequent export, regardless of their quantity and origin, the importer may choose for sampling to be carried out at the point of entry or at a production site authorized for post-entry quarantine monitoring. This choice must be communicated to SENASA before the phytosanitary inspection.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Likewise, the new general requirements will apply jointly with the specific requirements established for each species. In the event of incompatibility or discrepancy between them, the requirement ensuring a higher level of phytosanitary risk mitigation shall prevail.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Por otro lado, la Resoluci\u00f3n deja sin efecto la Resoluci\u00f3n Directoral No. 0006-2016-MINAGRI-SENASA-DSV y la Resoluci\u00f3n Directoral No. 0051-2015-MINAGRI-SENASA-DSV, y declara inaplicables los requisitos fitosanitarios generales previstos en el art\u00edculo 2 de la Resoluci\u00f3n Directoral No. 342-2002-AG-SENASA-DGSV para las semillas sexuales comprendidas en su Anexo 3.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Finally, shipments with phytosanitary import permits issued before the Resolution enters into force may continue with their import procedure, without the possibility of extension. The Resolution will enter into force on November 17, 2026.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2544836-1\" target=\"_blank\" rel=\"noopener\">https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2544836-1<\/a><\/p>\n\n\n\n<ol start=\"7\" class=\"wp-block-list\">\n<li><strong>SENASA ESTABLISHES LABORATORY ANALYSIS REQUIREMENTS FOR THE IMPORT OF TRUE SEEDS<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 20, 2026, Directorial Resolution No. D000031-2026-MIDAGRI- SENASA-DSV was published in the Official Gazette \u201cEl Peruano\u201d, through which the National Agrarian Health Service \u2013 SENASA establishes phytosanitary requirements related to the laboratory analyses applicable to imported true seeds, regardless of their quantity and use. It also approves the \u201cList of species, analyses and quantities required for phytosanitary diagnosis of true seeds\u201d.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Why is it important?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">According to SENASA, visual inspection of seeds makes it possible to detect certain insects and mites; however, most pathogens that can be carried by seeds, such as bacteria, fungi, nematodes, viroids and viruses, require specialized examinations or laboratory tests for their detection.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In this context, the Resolution seeks to standardize the quantities of seeds to be taken as samples and the phytosanitary analyses to be performed during import processes, in order to reduce the risk of introduction and spread of pests.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What do they establish?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Shipments of true seeds that, according to their phytosanitary import requirements, are subject to laboratory analysis must comply with the quantities and analyses established in the List approved by the Resolution. These analyses are mandatory and complementary to those required for the regulated pests in the respective phytosanitary import requirements.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In addition:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>When the country of origin of a given species is not included in the List, the same quantities of seeds provided for the other countries for that species will apply, and the analyses will be performed considering the pests regulated in its import requirements.<\/li>\n\n\n\n<li>When the species is not included in the List and its import requirements specify regulated pests, minimum quantities of 25,000 seeds for weed analysis; 1,000 for mycological analysis; 1,000 for bacteriological analysis; 3,000 for virological analysis; and 10 grams for nematological analysis are established.<\/li>\n\n\n\n<li>When the species is not included in the List and its import requirements do not specify regulated pests, the minimum samples will be 1,000 seeds for mycological analysis, 1,000 for bacteriological analysis and 25,000 for weed analysis.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">If sampling is carried out at a production site authorized for post-entry quarantine monitoring, the plants grown from the imported seeds must reach a certain level of development before sampling: the second pair of true leaves for dicotyledons or three (3) to four (4) true leaves for monocotyledons. In these cases, a minimum of one hundred (100) plants must be planted.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">On the other hand, the phytosanitary analyses will be notified by the SENASA inspector and will only be processed upon timely payment by the importer. Likewise, if the presence of pests is suspected, SENASA may order additional phytosanitary analyses, the cost of which must also be borne by the importer.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Resolution further provides that the List may be updated by the Plant Quarantine Subdirectorate through SENASA&#039;s digital platform. Amendments related to seed quantities or phytosanitary analyses will enter into force on the tenth (10th) business day after their update, except those relating to the inclusion of new species and\/or countries.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Finally, the Resolution will enter into force on November 17, 2026, granting a prior period to facilitate the technical adaptation of regulated parties and guarantee the continuity of seed trade.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2544847-1\" target=\"_blank\" rel=\"noopener\">https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2544847-1<\/a><\/p>\n\n\n\n<ol start=\"8\" class=\"wp-block-list\">\n<li><strong>DRAFT AMENDMENT TO THE ENVIRONMENTAL MANAGEMENT REGULATIONS FOR THE AGRICULTURAL AND IRRIGATION SECTOR PUBLISHED<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 20, 2026, Ministerial Resolution No. D000325-2026-MIDAGRI-DM was published in the Official Gazette \u201cEl Peruano\u201d, through which the Ministry of Agrarian Development and Irrigation \u2013 MIDAGRI orders the publication of the draft Supreme Decree amending the Environmental Management Regulations for the Agricultural and Irrigation Sector (RGASAR), approved by Supreme Decree No. 006-2024-MIDAGRI, as well as its Statement of Reasons.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The draft Supreme Decree and its Statement of Reasons will be published on MIDAGRI&#039;s digital platform for a period of fifteen (15) calendar days, counted from the business day following the publication of the Ministerial Resolution and its Annex in the Official Gazette El Peruano. During this period, public entities, private institutions and citizens may submit observations, comments, contributions, recommendations and suggestions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Los comentarios podr\u00e1n remitirse utilizando el \u201cFormato de Observaciones, Comentarios y\/o Aportes\u201d aprobado como Anexo de la Resoluci\u00f3n, a trav\u00e9s de la Mesa de Partes Virtual del MIDAGRI o al correo electr\u00f3nico&nbsp;<a href=\"mailto:consultas_dgaaa@midagri.gob.pe\">consultas_dgaaa@midagri.gob.pe<\/a>. La Direcci\u00f3n General de Asuntos Ambientales Agrarios estar\u00e1 a cargo de recibir, procesar, sistematizar y analizar los aportes para la elaboraci\u00f3n de la propuesta final.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What is proposed to be amended?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">According to the Resolution, the draft proposes amendments mainly related to the following aspects:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Clarifications regarding the Preliminary Environmental Assessment (EVAP).<\/li>\n\n\n\n<li>The updating of environmental studies.<\/li>\n\n\n\n<li>Amendments to the provisions applicable to the Environmental Technical Sheet (FTA) and the Detailed Closure Plan (PCD).<\/li>\n\n\n\n<li>The establishment of criteria for the classification and equivalence of environmental studies approved prior to the Advance Classification.<\/li>\n\n\n\n<li>The exceptional extension of the deadlines for the environmental adaptation of ongoing activities that do not have an approved environmental management instrument.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Specifically, the amendment process covers article 32, numerals 58.1 and 58.2 of article 58, numeral 70.4 of article 70, numerals 73.7, 73.10 and 73.11 of article 73 and the Eleventh Final Complementary Provision of the RGASAR.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2545225-1\" target=\"_blank\" rel=\"noopener\">https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2545225-1<\/a><\/p>\n\n\n\n<ol start=\"9\" class=\"wp-block-list\">\n<li><strong>PROVISIONS APPROVED TO ASSESS THE TECHNICAL SUITABILITY OF REGIONAL HEALTH AUTHORITIES FOR THE CERTIFICATION OF GENERAL PRINCIPLES OF HYGIENE<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 25, 2026, Ministerial Resolution No. 730-2026\/MINSA was published in the Official Gazette \u201cEl Peruano\u201d, approving Sanitary Directive No. 169- MINSA\/DIGESA-2026, which establishes the provisions for the technical suitability of the Regional Health Authority in the application and verification of the certification of General Principles of Food Hygiene of the Codex Alimentarius.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Why is it important?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The new Directive establishes the procedure by which the General Directorate of Environmental Health and Food Safety \u2013 DIGESA will assess the technical suitability of the Regional Health Directorates (DIRESA), Regional Health Offices (GERESA) or their equivalents, so that they may exercise the function of certifying the Codex Alimentarius GPH in their respective jurisdictions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A favorable assessment will be issued by DIGESA through a report, on the basis of which the list of regional authorities with technical suitability for the application and verification of GPH certification will be approved by Directorial Resolution. Suitability will be valid for two (2) years, renewable for the same period, provided that the original conditions for obtaining it are maintained, which will be periodically assessed by DIGESA.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To obtain and maintain such suitability, regional authorities must, among other things, permanently have professionals trained to carry out sanitary inspections; have computer equipment and calibrated measuring equipment; maintain the documentary records of the inspections and audits carried out; and register the certifications issued in the \u201cPGH regiones\u201d web information system administered by DIGESA.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Once technical suitability is obtained, DIRESA\/GERESA may carry out GPH certification throughout their jurisdiction, applicable to establishments that manufacture, store and portion industrialized food, as well as establishments engaged in food preparation in collective catering services.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Directive also establishes the stages to be observed during sanitary inspections or audits for certification purposes, including activities prior to the intervention, the inspection at the establishment and subsequent actions. During the inspection, among other aspects, the corresponding documentation, the processes and records related to GPH and their application in accordance with the Codex Alimentarius will be verified.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In this sense, the regulation is relevant for companies in the food and beverage sector located in the regions, as it establishes the conditions under which regional authorities may exercise the function of certifying General Principles of Hygiene, as well as the framework they must observe during the inspections and audits carried out for that purpose.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/www.gob.pe\/institucion\/minsa\/normaslegales\/8516669-730-2026-minsa\" target=\"_blank\" rel=\"noopener\">https:\/\/www.gob.pe\/institucion\/minsa\/normaslegales\/8516669-730-2026-minsa<\/a><\/p>\n\n\n\n<ol start=\"10\" class=\"wp-block-list\">\n<li><strong>AMENDMENT TO THE \u201cPROVISIONS OF THE ELECTRONIC TRANSACTION MODEL FOR THE PROCESS OF ACCREDITING INSURED PERSONS IN UNIVERSAL HEALTH INSURANCE \u2013 ACREDITA SALUD MODEL\u201d<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 26, 2026, Superintendency Resolution No. 000143-2026- SUSALUD\/SUP was published in the Official Gazette \u201cEl Peruano\u201d, amending the \u201cProvisions of the Electronic Transaction Model for the Process of Accrediting Insured Persons in Universal Health Insurance \u2013 Acredita Salud Model\u201d, approved by Superintendency Resolution No. 034-2025-SUSALUD\/S.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Why is it important?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The ACREDITA SALUD Model is a mandatory standard for the electronic transmission of the insured person accreditation process between Health Insurance Fund Management Institutions (IAFAS) and Health Service Provider Institutions (IPRESS), through SUSALUD&#039;s information platform.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Resolution extends until October 31, 2026 the maximum deadline for public, private or mixed IAFAS that have not yet implemented the ACREDITA SALUD Model to complete that process.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The deadline is also extended until the same date for private IPRESS that are using the SITEDS CLIENTE application to progressively migrate to the ACREDITA SALUD Platform or, alternatively, adapt their own systems in accordance with the standards of the ACREDITA SALUD Model.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The extension responds to the progressive advance in the implementation of the new model. According to SUSALUD, 43 of the 48 IAFAS (90%) have already completed the migration of their web services. In the case of private IPRESS, of the 508 that used SITEDS CLIENTE, 386 have already migrated to ACREDITA SALUD, while the rest require additional time to adapt their hospital management systems or care platforms.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In this sense, private IAFAS and IPRESS that are still pending adaptation have an additional period until October 31, 2026 to complete the corresponding implementation. During this period, SUSALUD will continue to provide technical assistance and carry out follow-up actions to achieve full compliance with the ACREDITA SALUD Model.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2547391-1\" target=\"_blank\" rel=\"noopener\">https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2547391-1<\/a><\/p>\n\n\n\n<ol start=\"11\" class=\"wp-block-list\">\n<li><strong>DIRECTIVE REGULATING THE ELECTRONIC MAILBOX AT SUSALUD APPROVED<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 28, 2026, Superintendency Resolution No. 000147-2026- SUSALUD\/SUP was published in the Official Gazette \u201cEl Peruano\u201d, approving the \u201cDirective regulating the guidelines, schedule, and technical and administrative criteria for the mandatory notification procedure via electronic mailbox and the assignment of the electronic mailbox at the National Health Superintendency \u2013 SUSALUD\u201d.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Directive is issued within the framework of Supreme Decree No. 009-2026- SA, which approved SUSALUD&#039;s Regulations on mandatory notification via electronic mailbox, in order to optimize the efficiency, effectiveness and speed of administrative procedures and actions, while guaranteeing the right of regulated parties to due notification.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Why is it important?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The regulation sets out the rules necessary to progressively implement the mandatory use of the electronic mailbox as SUSALUD&#039;s notification mechanism, including the guidelines, technical and administrative criteria, as well as the corresponding implementation schedule.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Consequently, regulated parties within SUSALUD&#039;s scope of action should pay special attention to the implementation of this mechanism, as the electronic mailbox will become the channel through which the authority may serve the notifications corresponding to its administrative procedures and actions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2548937-1\" target=\"_blank\" rel=\"noopener\">https:\/\/busquedas.elperuano.pe\/dispositivo\/NL\/2548937-1<\/a><\/p>\n\n\n\n<ol start=\"12\" class=\"wp-block-list\">\n<li><strong>DRAFT GUIDELINES FOR GUIDANCE-ORIENTED INSPECTIONS BY THE SUPERVISORY OFFICE FOR HEALTH SERVICE PROVIDER INSTITUTIONS<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 28, 2026, Superintendency Resolution No. 000144-2026- SUSALUD\/SUP was published in the Official Gazette \u201cEl Peruano\u201d, ordering the publication of a draft regulation approving the \u201cGuidelines for Guidance-Oriented Inspections by the Supervisory Office for Health Service Provider Institutions\u201d.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What does it propose?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The purpose of the draft is to establish the guidelines that SUSALUD must follow to carry out guidance-oriented inspections of IPRESS and UGIPRESS, led by the Supervisory Office for Health Service Provider Institutions \u2013 ISIPRESS.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Unlike an inspection aimed mainly at determining liability, the purpose of this modality is to identify risks and notify alerts to regulated parties so that they improve their management, within the framework of protecting the rights of health service users.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The draft establishes that these inspections may be carried out, among other scenarios, during health emergencies; with respect to IPRESS or UGIPRESS affected by emergencies or disasters; during their preparation for weather events; and in the event of large-scale events taking place in the country.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The inspection will also comprise four stages: planning, execution, issuance of reports and follow-up. During its execution, SUSALUD may carry out direct observations, interviews and documentary investigations, recording the verified facts in an Inspection Record.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Inspections may be comprehensive or selective; announced or unannounced; and scheduled or unscheduled. In the case of announced inspections, SUSALUD must give notice no less than five (5) business days in advance.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Why is it important?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Although the purpose of these inspections is mainly preventive and guidance- oriented, this does not prevent the facts detected from having subsequent consequences for the IPRESS.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In particular, during the inspection the IPRESS or UGIPRESS may assume commitments and deadlines to implement immediate improvement actions. If harm or an imminent risk to people&#039;s life or health is identified, the draft provides that a new, non-guidance-oriented inspection should be recommended as soon as possible.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In addition, failure to comply with the commitments assumed by the IPRESS or UGIPRESS, as well as obstruction of the inspection, may lead to the issuance of an Initial Report on Alleged Infractions. Subsequently, if it is concluded that there is evidence of the commission of one or more infractions, the Final Report may recommend the initiation of an administrative sanctioning proceeding (PAS) and be forwarded to the Enforcement and Sanctions Office.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Finally, the draft contemplates a field follow-up stage, through which SUSALUD will verify whether the actions implemented by the IPRESS or UGIPRESS effectively mitigated the risks identified during the inspection.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In this sense, the draft seeks to establish a preventive inspection mechanism, allowing IPRESS to identify and correct risks; however, failure to comply with the commitments assumed during that process or obstruction of the inspection may lead to actions aimed at initiating a PAS.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/www.gob.pe\/institucion\/susalud\/normaslegales\/8531674-000144-2026-susalud-sup\" target=\"_blank\" rel=\"noopener\">https:\/\/www.gob.pe\/institucion\/susalud\/normaslegales\/8531674-000144-2026-susalud-sup<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">NOTICES<\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>DIGESA PROVIDES CLARIFICATIONS REGARDING MINSA&#039;S NEW TUPA<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 03, 2026, the General Directorate of Environmental Health and Food Safety \u2013 DIGESA published on its institutional website Notice No. 05-2026- DIGESA\/MINSA, providing clarifications on the handling of administrative procedures following the approval of the Ministry of Health&#039;s new Consolidated Text of Administrative Procedures (TUPA).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The new TUPA was approved by Supreme Decree No. 011-2026-SA and has been in force since July 22, 2026.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">According to DIGESA, the new TUPA incorporates only two administrative procedures under its responsibility:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Sanitary authorization of the wastewater treatment and final disposal system with ground infiltration.<\/li>\n\n\n\n<li>Sanitary authorization for the operation of cemeteries and\/or crematoriums.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">In this sense, DIGESA has specified that the other procedures it administers, including sanitary registrations, certifications and sanitary permits, will continue to be handled normally.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Likewise, if the Foreign Trade Single Window (VUCE) charges processing fees for procedures that should be free of charge, DIGESA has stated that it will guarantee the refund of the amounts paid.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Finally, DIGESA reported that it is coordinating with MINCETUR the technical and administrative adjustments necessary in VUCE to implement the new service scheme.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/www.digesa.minsa.gob.pe\/COMUNICADO_05-2026-DIGESA-MINSA-01.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/www.digesa.minsa.gob.pe\/COMUNICADO_05-2026-DIGESA-MINSA-01.pdf<\/a><\/p>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><strong>DIGESA ESTABLISHES REQUIREMENTS FOR REQUESTING REFUNDS DUE TO THE APPROVAL OF THE NEW TUPA<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 12, 2026, the General Directorate of Environmental Health and Food Safety \u2013 DIGESA published on its institutional website Notice No. 011-2026-SA, establishing the requirements for requesting refunds due to the approval of the new TUPA.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In this regard, it was reported that, due to the entry into force of the new TUPA as of July 22, 2026, refunds of payments may be requested from MINSA by meeting the following requirements:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Annex 1 Form: Fill out the refund form for undue payment.<\/li>\n\n\n\n<li>Exact data: The company&#039;s information must match its file at DIGESA.<\/li>\n\n\n\n<li>Identity: Copy of the legal representative&#039;s DNI.<\/li>\n\n\n\n<li>Proof of payment: Legible copy of the voucher or bank transfer.<\/li>\n\n\n\n<li>Company registration: Current RUC record.<\/li>\n\n\n\n<li>Financial and contact details: Savings account number, Interbank Account Code (CCI), email and telephone.<\/li>\n\n\n\n<li>Legal signature: The document must be signed by the legal representative.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">El tr\u00e1mite se realiza a trav\u00e9s de la mesa de partes en l\u00ednea del MINSA:&nbsp;<a href=\"https:\/\/sgd.minsa.gob.pe\/appmesapartesenlinea\/inicio?tid=2*mesadepartes#\" target=\"_blank\" rel=\"noopener\">https:\/\/sgd.minsa.gob.pe\/appmesapartesenlinea\/inicio?tid=2*mesadepartes#<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/www.digesa.minsa.gob.pe\/COMUNICADO_06-2026-DIGESA-MINSA-01.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/www.digesa.minsa.gob.pe\/COMUNICADO_06-2026-DIGESA-MINSA-01.pdf<\/a><\/p>\n\n\n\n<ol start=\"3\" class=\"wp-block-list\">\n<li><strong>DIGEMID REPORTS ON BUREAUCRATIC BARRIERS DECLARED BY INDECOPI FOR THE MANUFACTURE AND MARKETING OF HYPERBARIC CHAMBERS<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 03, 2026, the General Directorate of Medicines, Supplies and Drugs \u2013 DIGEMID issued Notice No. 10-2026, reporting that the Ministry of Health was notified of Resolution No. 0086-2026\/CEB-INDECOPI, issued by INDECOPI&#039;s Commission for the Elimination of Bureaucratic Barriers. That resolution declared founded the complaint filed by HYPERBARIC S.A.C. and classified various requirements applicable to the manufacture and marketing of hyperbaric chambers as illegal and\/or unreasonable bureaucratic barriers.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The requirements declared illegal bureaucratic barriers mainly include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Conducting medical and laboratory examinations of personnel upon hiring and periodically.<\/li>\n\n\n\n<li>The obligation to have sanitation and pest control records, as well as certain storage, manufacturing and quarantine areas.<\/li>\n\n\n\n<li>The obligation to have responsible technical personnel such as a Production Manager, Quality Assurance Manager and Quality Control Manager.<\/li>\n\n\n\n<li>The requirement to have Good Manufacturing Practices (GMP) Certification to carry out activities of manufacturing and marketing hyperbaric chambers.<\/li>\n\n\n\n<li>The requirement that the quality assurance system and the production and quality control areas operate solely under the management of pharmaceutical chemists.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">INDECOPI also declared as unreasonable bureaucratic barriers certain requirements relating to the physical separation and independence of manufacturing and storage areas, the designation of responsible technical personnel, Good Manufacturing Practices Certification and the exclusive management by pharmaceutical chemists of certain areas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Finally, DIGEMID specifies that Resolution No. 0086-2026\/CEB-INDECOPI declared, with general effects, as illegal bureaucratic barriers the requirements to have independent and physically separated manufacturing and storage areas, that certain areas operate solely under the management of pharmaceutical chemists and that there be responsible technical personnel such as a Production Manager, Quality Assurance Manager and Quality Control Manager, in the terms set forth in articles 94, 105 and 108 of the Regulations on Pharmaceutical Establishments, approved by Supreme Decree No. 014-2011-SA.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/www.digemid.minsa.gob.pe\/webDigemid\/comunicados\/2026\/comunicado-n-010-2026\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.digemid.minsa.gob.pe\/webDigemid\/comunicados\/2026\/comunicado-n-010-2026\/<\/a><\/p>\n\n\n\n<ol start=\"4\" class=\"wp-block-list\">\n<li><strong>DIGEMID URGES DRUGSTORES TO ENSURE THE PRESENCE OF THE TECHNICAL DIRECTOR DURING THEIR OPENING HOURS<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 25, 2026, the General Directorate of Medicines, Supplies and Drugs \u2013 DIGEMID published on its institutional website Notice No. 012-2026-DIGEMID, through which DIGEMID urges drugstores to guarantee the effective availability of the establishment and the presence of the Technical Director during the declared opening hours, in order to ensure timely attention to sanitary control, surveillance and inspection actions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Why is it important?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DIGEMID specifies that drugstores may freely establish and organize their opening hours according to their operational and commercial needs; however, such hours must not limit, prevent or hinder the control and surveillance functions of the Health Authority. In this sense, it states that the hours declared by the drugstore must include the working hours of the competent health authority, currently established between 08:00 and 17:00, Monday through Friday.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DIGEMID also urges drugstores that import, store, distribute and\/or market pharmaceutical products, medical devices and sanitary products to guarantee the effective presence of their Technical Director for a minimum of four (4) hours a day, consistent with the establishment&#039;s declared hours and within the Health Authority&#039;s institutional working hours.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The presence of the Technical Director seeks to ensure a timely technical response to sanitary alerts, product holds or recalls, suspected counterfeit or adulterated products, quality, safety or efficacy issues, information requests, inspections and other situations that may compromise public health.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Differentiated regime according to risk level<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As the main new development, DIGEMID states that it may establish, following a technical and sanitary assessment, a differentiated regime of Technical Director availability for certain drugstores, based on the risk level of their activities.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Exceptionally, the minimum availability of three (3) to four (4) hours a day may be adjusted to two (2) or three (3) days a week, when the nature, complexity, risk level and activities carried out by the drugstore so justify. This regime will require prior assessment and authorization by DIGEMID or the competent Health Authority.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Drugstores that may be considered for this regime include, among others, those that exclusively carry out activities related to Class I medical devices, dental instruments and supplies, medical, surgical and dental equipment, certain low- risk medical devices and biomedical equipment, as well as certain sanitary products. Application of the regime will not be automatic, but will depend on the assessment of aspects such as the type of product, sanitary risk level, authorized activities, volume of operations, compliance history and complexity of the supply chain.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Finally, DIGEMID recommends that drugstores review their opening hours and professional attendance, strengthen their internal communication mechanisms, keep the information on the Technical Director and\/or assistant up to date and guarantee an immediate response to alerts and requests from the Health Authority.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/www.digemid.minsa.gob.pe\/webDigemid\/comunicados\/2026\/comunicado-n-012-2026\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.digemid.minsa.gob.pe\/webDigemid\/comunicados\/2026\/comunicado-n-012-2026\/<\/a><\/p>\n\n\n\n<ol start=\"5\" class=\"wp-block-list\">\n<li><strong>DIGEMID URGES PHARMACIES AND DRUGSTORES TO STRICTLY COMPLY WITH THEIR DECLARED AND AUTHORIZED OPENING HOURS<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 25, 2026, the General Directorate of Medicines, Supplies and Drugs \u2013 DIGEMID published on its institutional website Notice No. 013-2026-DIGEMID, through which DIGEMID urges pharmacies and drugstores to strictly comply with their declared and authorized opening hours.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The measure is part of the strengthening of sanitary surveillance actions and the increase in alerts related to substandard, counterfeit, adulterated or expired products, or products with quality, safety or efficacy issues or inadequate storage and conservation conditions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Why is it important?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DIGEMID specifies that pharmacies and drugstores must remain open and operational throughout their declared and authorized opening hours, in order to allow DIGEMID, DIRIS, DIRESA, GERESA or their equivalents to carry out the corresponding sanitary inspection, control and surveillance actions. It also urges establishments to avoid declaring hours they cannot effectively comply with.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In addition, DIGEMID states that establishments must organize their opening hours so as to include the working hours of the Health Authority, in order to facilitate, among other actions, sanitary inspection and surveillance, verification of products and storage conditions, the presence of the Technical Director, the execution of safety measures and attention to sanitary alerts.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The notice also emphasizes that compliance with opening hours must be coordinated with the obligations corresponding to the establishment&#039;s Technical Direction, highlighting the importance of the effective presence of the responsible professional while the pharmacy or drugstore is operating.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What do we recommend?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We recommend that pharmacies and drugstores review the opening hours declared to the Health Authority and verify that they match the hours actually kept by the establishment. It is also advisable to review the coverage of the Technical Direction during those hours and ensure that the establishment is available for sanitary inspection and surveillance actions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If the currently declared hours cannot be effectively complied with, we recommend assessing their modification before the competent Health Authority, especially considering DIGEMID&#039;s call for the establishment&#039;s hours to include the working hours of the health authority.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/www.digemid.minsa.gob.pe\/webDigemid\/comunicados\/2026\/comunicado-n-013-2026\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.digemid.minsa.gob.pe\/webDigemid\/comunicados\/2026\/comunicado-n-013-2026\/<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">PUBLICATIONS<\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>LABORATORIES PENDING GOOD MANUFACTURING PRACTICES CERTIFICATION BY THE ANM<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">On August 18, 2026, the Directorate of Medicines, Supplies and Drugs \u2013 DIGEMID published on its official website the Single List of foreign manufacturing laboratories of pharmaceutical products pending Good Manufacturing Practices certification by the ANM, updated as of July 31, 2026.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Why is it important?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pursuant to Supreme Decree No. 012-2023-SA, until May 23, 2028 DIGEMID will accept, for the import of pharmaceutical products, Good Manufacturing Practices Certificates issued by the Competent Authority of the country of origin or documents recognized as equivalent.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This regime applies provided that the manufacturing laboratories are included in the Single List of Manufacturing Laboratories of Pharmaceutical Products located abroad pending Good Manufacturing Practices certification.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Recommendation<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We recommend periodically checking the lists published by DIGEMID in order to confirm the inclusion of the manufacturing laboratory and determine the documentation applicable to the import of its products.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/www.digemid.minsa.gob.pe\/webDigemid\/publicaciones\/establecimientos\/laboratorios-pendientes-de-certificacion\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.digemid.minsa.gob.pe\/webDigemid\/publicaciones\/establecimientos\/laboratorios-pendientes-de-certificacion\/<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">BILLS<\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>LEGISLATIVE PROPOSAL TO PROMOTE FOOD SAFETY FOR CONSUMERS BY STRENGTHENING THE SANITARY CONTROL AND SURVEILLANCE SYSTEM<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><em>N\u00b0 de Proyecto: 00011-2026-2031-CD<br>Fecha de presentaci\u00f3n: 10\/08\/2026<br>Propuesta legislativa: Ley que promueve la inocuidad de los alimentos a favor de los consumidores mediante el fortalecimiento del sistema de control y vigilancia sanitaria.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Issue:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Although national regulations recognize the importance of food safety, there is insufficient capacity of the national sanitary control and surveillance system to guarantee the safety of food intended for human consumption. This is mainly due to weak product traceability, deficiencies in coordination between health authorities and limited enforcement capacities at the regional and local levels. It also identifies a predominantly reactive approach to risks arising from residues of pesticides, veterinary drugs, heavy metals and microbiological contaminants.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Therefore, the need was identified to improve the strategic coordination system between SENASA, DIGESA, SANIPES, regional governments and local governments, respecting their competences but enhancing their capacity for joint action.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What does it propose?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This bill proposes to strengthen the national system for sanitary control and surveillance of food, guaranteeing safety throughout the entire food chain and effectively protecting consumers&#039; health.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">To this end, it was proposed to amend Legislative Decree No. 1062, which approves the Food Safety Law, to strengthen the sanitary control and surveillance system. Its main measures include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Strengthening coordination between SENASA, DIGESA, SANIPES, regional governments and local governments, specifying their responsibilities in food control and surveillance.<\/li>\n\n\n\n<li>Establishing mandatory compliance with Good Agricultural Practices (GAP) and classifying as a very serious infraction the improper use of agricultural pesticides that poses a risk to public health or the environment.<\/li>\n\n\n\n<li>Creating an agricultural traceability system that makes it possible to identify and track agricultural products from the field or farm to the consumer, including information on their origin, processing, distribution and sale.<\/li>\n\n\n\n<li>Implementing technical assistance and training programs for local governments, including training in sanitary inspection, access to accredited laboratories and guidelines for monitoring pesticide residues and other contaminants.<\/li>\n\n\n\n<li>Ordering the detention, market withdrawal or prohibition of sale of food that exceeds the permitted limits of pesticides, veterinary drugs, heavy metals, microbiological contaminants or other sanitary parameters.<\/li>\n\n\n\n<li>Establishing an obligation for SENASA, DIGESA and SANIPES to publish information obtained from their monitoring processes, which must also be disseminated by INDECOPI through the Consumer Alert System.<\/li>\n\n\n\n<li>The Executive Branch would have 150 calendar days from the entry into force of the law to adapt its regulations.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/wb2server.congreso.gob.pe\/spleyportal\/#\/expediente\/2026\/11\" target=\"_blank\" rel=\"noopener\">https:\/\/wb2server.congreso.gob.pe\/spleyportal\/#\/expediente\/2026\/11<\/a><\/p>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><strong>LEGISLATIVE PROPOSAL TO GUARANTEE THE LOCATION, RESERVATION AND TIMELY DELIVERY OF MEDICINES IN PUBLIC HEALTH NETWORKS<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><em>N\u00b0 de Proyecto: 00084-2026-2031-CD<br>Fecha de presentaci\u00f3n: 21\/08\/2026<br>Propuesta legislativa: Proposici\u00f3n Legislativa que garantiza la ubicaci\u00f3n, reserva y entrega oportuna de medicamentos en las redes p\u00fablicas de salud.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Issue:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Currently, although health regulations provide for the possibility of partial dispensing of prescribed medicines, there is no uniform regulation as to what happens to the quantity pending delivery when the health facility does not have full or partial stock.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">According to the bill, this situation creates a gap in continuity of care, as users may be forced to make new consultations and trips to locate the medicine, without necessarily having information on its availability at other facilities in the same network or a mechanism to track the quantity pending dispensing.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What does it propose?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This bill proposes to establish a minimum standard of action for public health networks in the event of a total or partial shortage of medicines, including, among others, the following measures:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Providing users with a physical or electronic record, free of charge, when the medicine is not fully or partially available. It must identify the prescription, the medicine, the quantity dispensed and the quantity pending.<\/li>\n\n\n\n<li>Before concluding the consultation, checking the availability of the medicine at other facilities in the same care network or funding institution. If stock is available, the user must be informed and, with their consent, a reservation must be made for up to 48 hours, unless storage or safety conditions require a shorter period.<\/li>\n\n\n\n<li>In the event of partial dispensing, keeping the pending quantity as not dispensed during the validity of the prescription, allowing it to be filled at another authorized facility in the same network.<\/li>\n\n\n\n<li>When there is no availability, generating a pending order linked to the prescription and enabling a free channel for the user to check its status. Restocking must also be communicated through the means chosen by the user.<\/li>\n\n\n\n<li>Implementing mechanisms for the internal redistribution of medicines within the network, especially considering those close to expiration or located at facilities with surplus stock.<\/li>\n\n\n\n<li>In situations of shortage, allowing the dispensing of an equivalent presentation or concentration, provided there is a protocol approved by the health authority, the corresponding clinical safeguards are observed and the user&#039;s informed consent is obtained.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Public institutions must also publish quarterly aggregated information on prescriptions partially filled or not filled due to lack of availability, reservations made, pending orders and the average time elapsed until effective dispensing. SUSALUD will be responsible for supervising compliance with these provisions within the scope of its competences.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/wb2server.congreso.gob.pe\/spleyportal\/#\/diputados\/expediente\/2026\/84\" target=\"_blank\" rel=\"noopener\">https:\/\/wb2server.congreso.gob.pe\/spleyportal\/#\/diputados\/expediente\/2026\/84<\/a><\/p>\n\n\n\n<ol start=\"3\" class=\"wp-block-list\">\n<li><strong>LEGISLATIVE PROPOSAL AMENDING LAW 31189 TO STRENGTHEN THE INTEROPERABILITY OF ENVIRONMENTAL AND HEALTH INFORMATION IN PORT AND INDUSTRIAL AREAS<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><em>N\u00b0 de Proyecto: 00087-2026-2031-CD<br>Fecha de presentaci\u00f3n: 24\/08\/2026<br>Propuesta legislativa: Proposici\u00f3n Legislativa que modifica la Ley 31189 para fortalecer la interoperabilidad de la informaci\u00f3n ambiental y sanitaria en zonas portuarias e industriales.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Issue:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">There is currently fragmented, heterogeneous or delayed use of the environmental and health information generated by the various public entities, which makes it difficult to use it to prioritize prevention, surveillance and response actions for health risks associated with exposure to heavy metals and other chemical substances. This issue is especially relevant in areas where population, port or industrial activities and various potential sources of contamination converge.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Although there are currently intersectoral coordination mechanisms and systems such as the National Environmental Information System (SINIA), the Bill notes that environmental and health systems handle different variables, units, territorial scales and access rules. Furthermore, Law No. 31189 does not establish common minimum criteria for identifying the source, date, method, coverage, uncertainty and validity of the information used.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This could make it difficult to compare information and lead to delayed responses or decisions based solely on a population&#039;s proximity to a possible source of contamination, rather than on a comprehensive assessment of the sources, exposure pathways, potentially exposed population and available evidence.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What does it propose?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The bill mainly proposes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Establishing that the PCM, MINSA and MINAM coordinate actions for the prevention, mitigation and response to health risks and harm arising from heavy metals and other chemical substances. The competent entities must also exchange aggregated or anonymized environmental and health information through SINIA and existing sector systems, applying common data quality and traceability rules.<\/li>\n\n\n\n<li>Creating an Integrated Territorial Exposure and Risk Sheet for areas where industrial, port, mining or hydrocarbon activities are carried out, where there are environmental liabilities or where multiple potential sources of contamination converge. This sheet would integrate information on potential sources, environmental monitoring results, possible exposure pathways, exposed or potentially exposed population, vulnerability factors, available biomonitoring, information gaps and measures adopted.<\/li>\n\n\n\n<li>Establishing a signal, assessment and response mechanism in the event of confirmed exceedance of applicable standards, unusual aggregated health findings, relevant biomonitoring results or other consistent evidence of a possible exposure pathway. In these scenarios, the health authority must verify the information, assess the possible exposure pathway and identify the potentially exposed or vulnerable population to determine the corresponding actions.<\/li>\n\n\n\n<li>Requiring entities to publish, at least every six months, the territorial sheets, information gaps, agreed measures and their degree of compliance, maintaining traceability regarding the source, date, version and processing of the data used.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">A relevant aspect for holders of industrial, port, mining and hydrocarbon activities is that the Bill expressly specifies that the territorial sheets will be prepared on the basis of information generated in compliance with currently applicable obligations and will not, by itself, create new monitoring or reporting obligations for holders of private activities.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Likewise, a population&#039;s proximity to a facility or potential source of contamination will not, by itself, be sufficient to prove exposure, causation or liability. Similarly, actions arising from this mechanism will not replace the assessment, supervision, enforcement, sanctioning or clinical care procedures established in current regulations.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Finally, if the Bill is approved, the Executive Branch must issue the regulations of the Law within sixty (60) calendar days following its publication.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/wb2server.congreso.gob.pe\/spleyportal\/#\/diputados\/expediente\/2026\/87\" target=\"_blank\" rel=\"noopener\">https:\/\/wb2server.congreso.gob.pe\/spleyportal\/#\/diputados\/expediente\/2026\/87<\/a><\/p>\n\n\n\n<ol start=\"4\" class=\"wp-block-list\">\n<li><strong>LEGISLATIVE PROPOSAL AMENDING LAW 27669, NURSING WORK LAW, TO STRENGTHEN THE PROFESSIONAL AUTONOMY OF NURSING<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><em>N\u00b0 de Proyecto: 00091-2026-2031-CD<br>Fecha de presentaci\u00f3n: 24\/08\/2026<br>Propuesta legislativa: Proposici\u00f3n Legislativa que modifica la Ley 27669, Ley del trabajo de la enfermera(o), para fortalecer la autonom\u00eda profesional de enfermer\u00eda.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Issue:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Currently, Law No. 27669 recognizes nursing professionals&#039; own functions and responsibilities, including providing comprehensive care based on the Nursing Care Process. However, the law does not expressly recognize that the nursing profession is autonomous, scientific and independent in nature, which may create uncertainty regarding the decisions these professionals may make within their own competences.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This is relevant mainly at the first level of care, given that there are category I-1 facilities that do not have a physician and in which nursing professionals may be one of the main health professionals available. In this context, the lack of clarity regarding their scope of autonomy could lead to restrictions on the performance of actions that properly belong to the profession.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Bill also identifies an issue regarding the use of the term \u201cdiagnosis\u201d, since its use without distinguishing the professional discipline could cause confusion between the diagnosis made by other health professionals and the nursing diagnosis, which is part of that profession&#039;s own methodological process.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Finally, it notes that current legislation prohibits anyone without the corresponding degree from using the title of Nurse, but does not contain an express prohibition on the use of the uniform or other insignia associated with the profession, which could mislead patients and other users of health services as to the professional status of the person attending them.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>What does it propose?<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Bill proposes to amend Law No. 27669 to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Expressly recognize that nursing is an autonomous, scientific and independent health sciences discipline, within the competences conferred by law, and that its practice is based on evidence-based practice.<\/li>\n\n\n\n<li>Expressly recognize that nursing professionals carry out the assessment, nursing diagnosis, planning, execution and evaluation of care, as part of the Nursing Care Process and in accordance with their professional training.<\/li>\n\n\n\n<li>Specify that a nursing diagnosis does not constitute a medical diagnosis nor does it authorize the nursing professional to assume competences attributed to other health professionals. Its purpose is to identify the needs and responses of the person, family or community that require nursing care.<\/li>\n\n\n\n<li>Prohibit anyone without the corresponding degree from using uniforms or other insignia related to the nursing profession, also providing for the application of article 362 of the Criminal Code regarding the use of symbols specific to the profession.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Likewise, if the Bill is approved, the Executive Branch must adapt the Regulations of Law No. 27669 within sixty (60) calendar days following its entry into force.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/wb2server.congreso.gob.pe\/spleyportal\/#\/diputados\/expediente\/2026\/91\" target=\"_blank\" rel=\"noopener\">https:\/\/wb2server.congreso.gob.pe\/spleyportal\/#\/diputados\/expediente\/2026\/91<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">NEWS<\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>MINSA: INTERAGENCY MEETING HELD TO PREVENT RISKS FROM LEAD-BASED PAINTS IN ORDER TO PROTECT THE HEALTH OF THE POPULATION<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">The Ministry of Health, through the General Directorate of Environmental Health and Food Safety (DIGESA), participated in a coordination meeting convened by the First Crime Prevention Prosecutor&#039;s Office of Lima Centro. The purpose of the meeting was to enhance preventive measures and consolidate interagency coordination to inspect paints and coating materials containing lead, as established in Law No. 31182.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As a result of the meeting, the participating institutions agreed to strengthen coordinated work through preventive monitoring actions, information exchange and technical coordination that contribute to the effective implementation of the regulations and to compliance with the obligations of manufacturers, importers and sellers of paints and coating materials.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/www.gob.pe\/institucion\/minsa\/noticias\/1426292-minsase-realiza-reunion-interinstitucional-para-prevenir-riesgos-enpinturas-con-plomo-para-proteger-la-salud-de-la-poblacion\" target=\"_blank\" rel=\"noopener\">https:\/\/www.gob.pe\/institucion\/minsa\/noticias\/1426292-minsase-realiza-reunion-interinstitucional-para-prevenir-riesgos-enpinturas-con-plomo-para-proteger-la-salud-de-la-poblacion<\/a><\/p>\n\n\n\n<ol start=\"2\" class=\"wp-block-list\">\n<li><strong>MINSA AND ESSALUD COORDINATE ACTIONS TO GUARANTEE CRITICAL MEDICINES FOR PATIENTS<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">MINSA reported that the General Directorate of Medicines, Supplies and Drugs \u2013 DIGEMID and EsSalud&#039;s Strategic Goods Supply Center \u2013 CEABE are coordinating actions aimed at preventing shortage risks and guaranteeing the continuity of treatment for patients who require critical medicines.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Within this framework, representatives of DIGEMID, CEABE and the Rebagliati, Almenara and Sabogal care networks assessed the availability of certain medicines and established actions to expedite their acquisition, import, customs clearance and corresponding quality controls.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The actions announced cover medicines for the treatment of patients with cancer, hemophilia, tuberculosis, HIV, and kidney, immune and heart diseases. The prioritized products include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Human immunoglobulin 5%.<\/li>\n\n\n\n<li>Injectable amiodarone.<\/li>\n\n\n\n<li>Epoetin alfa 4,000 IU.<\/li>\n\n\n\n<li>Factor IX.<\/li>\n\n\n\n<li>Asparaginase.<\/li>\n\n\n\n<li>Zidovudine.<\/li>\n\n\n\n<li>Ethambutol.<\/li>\n<\/ul>\n\n\n\n<ol start=\"3\" class=\"wp-block-list\">\n<li><strong>EXECUTIVE BRANCH PROPOSES TO REDUCE GAPS IN MEDICAL APPOINTMENTS, ACCESS TO MEDICINES AND BACKLOGGED SURGERIES<\/strong><\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">The Executive Branch announced its main priorities for the Health sector, aimed at reducing gaps in access to medical appointments and medicines, as well as pending surgeries.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In this regard, the measures seek to reduce waiting times and the number of patients whose care is being postponed, as well as to move toward a more responsive health system.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Thus, the Executive Branch has proposed, among its main lines of action:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Reducing gaps in access to medicines, as part of the measures aimed at guaranteeing timely care for patients.<\/li>\n\n\n\n<li>Reducing waiting times for medical appointments and reducing pending surgeries, prioritizing care for patients currently on waiting lists.<\/li>\n\n\n\n<li>Progressively strengthening health facilities and Integrated Health Networks, improving their infrastructure, equipment and capacity to treat diseases such as diabetes, hypertension and anemia.<\/li>\n\n\n\n<li>Using technological tools to bring health services closer to the population. The announced goal is that, by 2031, more than half of the prioritized Integrated Health Networks will be strengthened and have better conditions to provide timely and comprehensive care.<\/li>\n\n\n\n<li>Progressively implementing home care from the first level of care for older adults in situations of frailty, dependency or vulnerability, coordinating it with telemedicine and specialized care services.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Acceso:&nbsp;<a href=\"https:\/\/www.gob.pe\/institucion\/minsa\/noticias\/1432735-ejecutivo-plantea-reducir-las-brechas-de-citas-medicas-accesoa-medicamentos-e-intervenciones-quirurgicas-embalsadas\" target=\"_blank\" rel=\"noopener\">https:\/\/www.gob.pe\/institucion\/minsa\/noticias\/1432735-ejecutivo-plantea-reducir-las-brechas-de-citas-medicas-accesoa-medicamentos-e-intervenciones-quirurgicas-embalsadas<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">If you have any questions and\/or inquiries, contact us:<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Marta Fern\u00e1ndez Pepper<\/strong><br>Partner<br><a href=\"mailto:mfernandez@dclegal.pe\">mfernandez@dclegal.pe<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Jimena Zambrano L\u00f3pez<\/strong><br>Associate<br><a href=\"mailto:jzambrano@dclegal.pe\">jzambrano@dclegal.pe<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>NORMAS Con fecha 08 de agosto del 2026, se public\u00f3 en el Diario Oficial \u201cEl Peruano\u201d la Resoluci\u00f3n Directoral No. 121-2026-DIGEMID-DG-MINSA, mediante la cual se modifica el \u201cListado de Documentos Considerados equivalentes al Certificado de Buenas Pr\u00e1cticas de Manufactura\u201d. \u00bfPor qu\u00e9 es importante? Conforme a lo dispuesto en el Decreto Supremo No. 012-2023-SA, hasta el [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":482,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"dc_lectura":0,"dc_area":0,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-boletines"],"_links":{"self":[{"href":"https:\/\/diezcanseco.pe\/en\/wp-json\/wp\/v2\/posts\/467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/diezcanseco.pe\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/diezcanseco.pe\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/diezcanseco.pe\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/diezcanseco.pe\/en\/wp-json\/wp\/v2\/comments?post=467"}],"version-history":[{"count":3,"href":"https:\/\/diezcanseco.pe\/en\/wp-json\/wp\/v2\/posts\/467\/revisions"}],"predecessor-version":[{"id":481,"href":"https:\/\/diezcanseco.pe\/en\/wp-json\/wp\/v2\/posts\/467\/revisions\/481"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/diezcanseco.pe\/en\/wp-json\/wp\/v2\/media\/482"}],"wp:attachment":[{"href":"https:\/\/diezcanseco.pe\/en\/wp-json\/wp\/v2\/media?parent=467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/diezcanseco.pe\/en\/wp-json\/wp\/v2\/categories?post=467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/diezcanseco.pe\/en\/wp-json\/wp\/v2\/tags?post=467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}